From: Doctors’ preferences in de-escalating DMARDs in rheumatoid arthritis: a discrete choice experiment
Group 1 n = 48 | Group 2 n = 22 | Group 3 n = 26 | Group 4 n = 30 | Group 5 n = 30 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
β | SE | β | SE | β | SE | β | SE | β | SE | |
Opt-out1 chosen | 38% | 21% | 9% | 1% | 53% | |||||
Opt-out1 | -2.78*** | 0.23 | -5.33*** | 0.97 | -4.98*** | 0.83 | -5.70*** | 0.64 | -4.72*** | 0.41 |
DAS ≤ 3.22 | -0.59*** | 0.15 | -1.60** | 0.49 | -2.55*** | 0.57 | -0.59*** | 0.15 | -1.87*** | 0.27 |
Swollen joint count | ||||||||||
13 | -1.01*** | 0.19 | -3.24*** | 0.59 | -1.02 | 0.53 | -0.79*** | 0.19 | -3.53*** | 0.48 |
23 | -1.90*** | 0.22 | -6.06*** | 0.99 | -0.63* | 0.28 | -1.25*** | 0.21 | -3.92*** | 0.51 |
Patient history | ||||||||||
Erosive disease4 | -1.27*** | 0.20 | -0.73 | 0.40 | -1.23** | 0.38 | -0.58* | 0.24 | -1.29*** | 0.43 |
Remission difficult4 | -1.08*** | 0.20 | -0.95* | 0.46 | -1.42** | 0.42 | -0.44 | 0.27 | -1.79*** | 0.37 |
Erosive + remission difficult4 | -2.80*** | 0.25 | -1.14 | 0.62 | -2.99*** | 0.60 | -1.29*** | 0.30 | -2.79*** | 0.40 |
Remission duration 6 months5 | -0.41* | 0.16 | -1.17*** | 0.40 | -0.52 | 0.31 | -0.17 | 0.14 | -3.74 | - |
Patient not willing to de-escalate at start of visit6 | -1.61*** | 0.20 | -1.05*** | 0.30 | -0.98** | 0.30 | -1.14*** | 0.13 | -1.49*** | 0.27 |
Class probabilities, median (range) | 0.99 (0.55 – 0.99) | 0.99 (0.55 – 0.99) | 0.94 (0.58 – 0.99) | 0.99 (0.77 – 0.99) | 0.98 (0.57 – 0.99) |